CJC-1295 + Ipamorelin
Growth hormone-stimulating peptide combination for body composition, recovery, and sleep
Overview
CJC-1295 is a 30-amino acid GHRH (Growth Hormone Releasing Hormone) analog that stimulates sustained growth hormone secretion with minimal effect on cortisol and prolactin. Ipamorelin is a selective GH secretagogue that mimics ghrelin, stimulating GH release from the pituitary. Together, this combination produces a synergistic increase in growth hormone and IGF-1 levels, supporting fat loss, lean muscle gain, improved sleep, and accelerated recovery.
- Growth hormone optimization
- Lean body mass increase
- Fat loss (lipolysis)
- Sleep quality improvement
- Injury recovery acceleration
- Bone density support
- Immune system enhancement
- Increased energy and endurance
Dosage & Instructions
Form
Subcutaneous injection
Amount
As prescribed by your provider
Frequency
Daily — typically at bedtime
Timing
Bedtime on an empty stomach for optimal GH pulse alignment
Inject subcutaneously into the abdomen or thigh. Administer at bedtime to align with the body's natural GH release cycle. Rotate injection sites.
Dosage Schedule
| When | Dose | Notes |
|---|---|---|
| Daily (bedtime) | As prescribed | Bedtime dosing maximizes natural GH release |
| Duration | Typically 3–6 month cycles | Your provider will assess IGF-1 levels and adjust protocol |
Side Effects
Common
- Mild injection site redness or swelling
- Water retention (temporary)
- Tingling or numbness
- Increased hunger
Less Common
- Headache
- Fatigue
- Flushing
Serious — Seek Care
- Contact your provider if you experience significant joint pain, vision changes, or unusual swelling
Drug Interactions
- Inform your provider of all medications
- May interact with insulin and diabetes medications
- Glucocorticoids may reduce effectiveness